ArticleJournal of clinical microbiology2014

Multicenter evaluation of the new Vitek 2 yeast susceptibility test using new CLSI clinical breakpoints for fluconazole.

M A Pfaller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.